πŸ‡ΊπŸ‡Έ FDA
Patent

US 6184224

Antitumor dibenzofluorene derivatives

expired A61KA61K31/4453A61K31/495

Quick answer

US patent 6184224 (Antitumor dibenzofluorene derivatives) held by The Board of Regents of the University of Texas System expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/4453, A61K31/495, A61P, A61P35/00